Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Hemodynamic Response of Iloprost via Breelib in PAH
NCT03365479Completed
- Sponsor
- Justus Liebig University Giessen
- Start
- May 2017
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of iloprost in pulmonary arterial hypertension (PAH), sponsored by Justus Liebig University Giessen. Primary endpoint: Pulmonary Vascular Resistance. Started May 2017; status: completed.
02
Drugs
iloprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03365479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03365479.